SCHEMBL2200787

SCHEMBL2200787

CCCN(CCC)CCCCN(Cc1ccc(C#N)cc1)Cc1ccc(OC)cc1

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
RORC P51449 1/20 0.46
BCHE P06276 1/20 0.46
SNCA P37840 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201240 0.90 RORC (0.53) RORC
SCHEMBL15831721 0.83 HRH3 (0.59) RORC
SCHEMBL2201741 0.83 RORC (0.48) MAOBRORC
SCHEMBL20871138 0.82 HRH3 (0.55) BCHE
SCHEMBL22340925 0.81 HRH3 (0.53) BCHE
SCHEMBL20871425 0.81 HRH3 (0.53) BCHE
SCHEMBL20870804 0.81 HRH3 (0.53) BCHE
SCHEMBL22340881 0.81 HRH3 (0.53) BCHE
SCHEMBL2204043 0.81 RORC (0.49) RORC
SCHEMBL29334326 0.81 MAPT (0.59) BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof KUREHA CORPORATION 2008-11-27 US disclosed
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof KUREHA CORPORATION 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof BCAT2, BCAT1, MRPL9 MAOA 632/4885MAOB 311/4885RORC 4375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.